Zacks Investment Research upgraded shares of CRH Medical (NYSEAMERICAN:CRHM) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. The firm currently has $2.75 target price on the stock.
According to Zacks, “CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O’Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I – IV. It distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. “
Shares of CRH Medical (NYSEAMERICAN:CRHM) opened at $2.60 on Tuesday. The stock has a market capitalization of $229.48, a price-to-earnings ratio of 28.89 and a beta of 1.14. CRH Medical has a 12-month low of $1.46 and a 12-month high of $9.25.
COPYRIGHT VIOLATION NOTICE: “CRH Medical (CRHM) Upgraded by Zacks Investment Research to “Buy”” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3294890/crh-medical-crhm-upgraded-by-zacks-investment-research-to-buy.html.
CRH Medical Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.